血管内皮増殖因子阻害薬の世界市場（～2026年）

• 英文タイトル：Global Vascular Endothelial Growth Factor Inhibitor Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY12962
• 出版社/出版日：QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、116ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は血管内皮増殖因子阻害薬のグローバル市場について調査・分析したレポートです。種類別（経口薬、注射）市場規模、用途別（病院、外来手術センター、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別血管内皮増殖因子阻害薬の競争状況、市場シェア
・世界の血管内皮増殖因子阻害薬市場：種類別市場規模 2015年-2020年（経口薬、注射）
・世界の血管内皮増殖因子阻害薬市場：種類別市場規模予測 2021年-2026年（経口薬、注射）
・世界の血管内皮増殖因子阻害薬市場：用途別市場規模 2015年-2020年（病院、外来手術センター、がん研究所）
・世界の血管内皮増殖因子阻害薬市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、がん研究所）
・北米の血管内皮増殖因子阻害薬市場分析：米国、カナダ
・ヨーロッパの血管内皮増殖因子阻害薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの血管内皮増殖因子阻害薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の血管内皮増殖因子阻害薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの血管内皮増殖因子阻害薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Novartis、AstraZeneca、Bayer Healthcare、Merck、Genetech、Eli Lilly、Sanofi Aventis、GlaxoSmithKline、Bristol-Myer Squibb、Boehringer Ingelheim
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Vascular Endothelial Growth Factor Inhibitor Market
The global Vascular Endothelial Growth Factor Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Vascular Endothelial Growth Factor Inhibitor Scope and Market Size
Vascular Endothelial Growth Factor Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Endothelial Growth Factor Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Vascular Endothelial Growth Factor Inhibitor market is segmented into
Oral Medications
Injections

Segment by Application, the Vascular Endothelial Growth Factor Inhibitor market is segmented into
Hospitals
Ambulatory Surgical Centers
Cancer Research Institutes

Regional and Country-level Analysis
The Vascular Endothelial Growth Factor Inhibitor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vascular Endothelial Growth Factor Inhibitor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vascular Endothelial Growth Factor Inhibitor Market Share Analysis
Vascular Endothelial Growth Factor Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vascular Endothelial Growth Factor Inhibitor business, the date to enter into the Vascular Endothelial Growth Factor Inhibitor market, Vascular Endothelial Growth Factor Inhibitor product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Novartis
AstraZeneca
Bayer Healthcare
Merck
Genetech
Eli Lilly
Sanofi Aventis
GlaxoSmithKline
Bristol-Myer Squibb
Boehringer Ingelheim

レポート目次

1 Study Coverage
1.1 Vascular Endothelial Growth Factor Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Vascular Endothelial Growth Factor Inhibitor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vascular Endothelial Growth Factor Inhibitor Market Size Growth Rate by Type
1.4.2 Oral Medications
1.4.3 Injections
1.5 Market by Application
1.5.1 Global Vascular Endothelial Growth Factor Inhibitor Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Vascular Endothelial Growth Factor Inhibitor Market Size, Estimates and Forecasts
2.1.1 Global Vascular Endothelial Growth Factor Inhibitor Revenue 2015-2026
2.1.2 Global Vascular Endothelial Growth Factor Inhibitor Sales 2015-2026
2.2 Global Vascular Endothelial Growth Factor Inhibitor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vascular Endothelial Growth Factor Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vascular Endothelial Growth Factor Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Vascular Endothelial Growth Factor Inhibitor Competitor Landscape by Players
3.1 Vascular Endothelial Growth Factor Inhibitor Sales by Manufacturers
3.1.1 Vascular Endothelial Growth Factor Inhibitor Sales by Manufacturers (2015-2020)
3.1.2 Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Manufacturers (2015-2020)
3.2 Vascular Endothelial Growth Factor Inhibitor Revenue by Manufacturers
3.2.1 Vascular Endothelial Growth Factor Inhibitor Revenue by Manufacturers (2015-2020)
3.2.2 Vascular Endothelial Growth Factor Inhibitor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vascular Endothelial Growth Factor Inhibitor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor Inhibitor Revenue in 2019
3.2.5 Global Vascular Endothelial Growth Factor Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vascular Endothelial Growth Factor Inhibitor Price by Manufacturers
3.4 Vascular Endothelial Growth Factor Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Vascular Endothelial Growth Factor Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vascular Endothelial Growth Factor Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Vascular Endothelial Growth Factor Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Vascular Endothelial Growth Factor Inhibitor Market Size by Type (2015-2020)
4.1.1 Global Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020)
4.1.2 Global Vascular Endothelial Growth Factor Inhibitor Revenue by Type (2015-2020)
4.1.3 Vascular Endothelial Growth Factor Inhibitor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Type (2021-2026)
4.2.1 Global Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Vascular Endothelial Growth Factor Inhibitor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vascular Endothelial Growth Factor Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Vascular Endothelial Growth Factor Inhibitor Market Size by Application (2015-2020)
5.1.1 Global Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020)
5.1.2 Global Vascular Endothelial Growth Factor Inhibitor Revenue by Application (2015-2020)
5.1.3 Vascular Endothelial Growth Factor Inhibitor Price by Application (2015-2020)
5.2 Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Application (2021-2026)
5.2.1 Global Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Vascular Endothelial Growth Factor Inhibitor Price Forecast by Application (2021-2026)

6 North America
6.1 North America Vascular Endothelial Growth Factor Inhibitor by Country
6.1.1 North America Vascular Endothelial Growth Factor Inhibitor Sales by Country
6.1.2 North America Vascular Endothelial Growth Factor Inhibitor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Type
6.3 North America Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Application

7 Europe
7.1 Europe Vascular Endothelial Growth Factor Inhibitor by Country
7.1.1 Europe Vascular Endothelial Growth Factor Inhibitor Sales by Country
7.1.2 Europe Vascular Endothelial Growth Factor Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Type
7.3 Europe Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Vascular Endothelial Growth Factor Inhibitor by Region
8.1.1 Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Region
8.1.2 Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Type
8.3 Asia Pacific Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Application

9 Latin America
9.1 Latin America Vascular Endothelial Growth Factor Inhibitor by Country
9.1.1 Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Country
9.1.2 Latin America Vascular Endothelial Growth Factor Inhibitor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Type
9.3 Central & South America Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor by Country
10.1.1 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Country
10.1.2 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Type
10.3 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Vascular Endothelial Growth Factor Inhibitor Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Vascular Endothelial Growth Factor Inhibitor Products Offered
11.2.5 Novartis Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Vascular Endothelial Growth Factor Inhibitor Products Offered
11.3.5 AstraZeneca Related Developments
11.4 Bayer Healthcare
11.4.1 Bayer Healthcare Corporation Information
11.4.2 Bayer Healthcare Description and Business Overview
11.4.3 Bayer Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Healthcare Vascular Endothelial Growth Factor Inhibitor Products Offered
11.4.5 Bayer Healthcare Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Vascular Endothelial Growth Factor Inhibitor Products Offered
11.5.5 Merck Related Developments
11.6 Genetech
11.6.1 Genetech Corporation Information
11.6.2 Genetech Description and Business Overview
11.6.3 Genetech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genetech Vascular Endothelial Growth Factor Inhibitor Products Offered
11.6.5 Genetech Related Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description and Business Overview
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Vascular Endothelial Growth Factor Inhibitor Products Offered
11.7.5 Eli Lilly Related Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Description and Business Overview
11.8.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Aventis Vascular Endothelial Growth Factor Inhibitor Products Offered
11.8.5 Sanofi Aventis Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Vascular Endothelial Growth Factor Inhibitor Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Bristol-Myer Squibb
11.10.1 Bristol-Myer Squibb Corporation Information
11.10.2 Bristol-Myer Squibb Description and Business Overview
11.10.3 Bristol-Myer Squibb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bristol-Myer Squibb Vascular Endothelial Growth Factor Inhibitor Products Offered
11.10.5 Bristol-Myer Squibb Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Vascular Endothelial Growth Factor Inhibitor Products Offered
11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vascular Endothelial Growth Factor Inhibitor Market Estimates and Projections by Region
12.1.1 Global Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Regions 2021-2026
12.1.2 Global Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Regions 2021-2026
12.2 North America Vascular Endothelial Growth Factor Inhibitor Market Size Forecast (2021-2026)
12.2.1 North America: Vascular Endothelial Growth Factor Inhibitor Sales Forecast (2021-2026)
12.2.2 North America: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast (2021-2026)
12.2.3 North America: Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Country (2021-2026)
12.3 Europe Vascular Endothelial Growth Factor Inhibitor Market Size Forecast (2021-2026)
12.3.1 Europe: Vascular Endothelial Growth Factor Inhibitor Sales Forecast (2021-2026)
12.3.2 Europe: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast (2021-2026)
12.3.3 Europe: Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vascular Endothelial Growth Factor Inhibitor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vascular Endothelial Growth Factor Inhibitor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Region (2021-2026)
12.5 Latin America Vascular Endothelial Growth Factor Inhibitor Market Size Forecast (2021-2026)
12.5.1 Latin America: Vascular Endothelial Growth Factor Inhibitor Sales Forecast (2021-2026)
12.5.2 Latin America: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast (2021-2026)
12.5.3 Latin America: Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vascular Endothelial Growth Factor Inhibitor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vascular Endothelial Growth Factor Inhibitor Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vascular Endothelial Growth Factor Inhibitor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vascular Endothelial Growth Factor Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Vascular Endothelial Growth Factor Inhibitor Market Segments
Table 2. Ranking of Global Top Vascular Endothelial Growth Factor Inhibitor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vascular Endothelial Growth Factor Inhibitor Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Medications
Table 5. Major Manufacturers of Injections
Table 6. Global Vascular Endothelial Growth Factor Inhibitor Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Vascular Endothelial Growth Factor Inhibitor Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Vascular Endothelial Growth Factor Inhibitor Sales by Regions 2015-2020 (K Units)
Table 9. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Regions (2015-2020)
Table 10. Global Vascular Endothelial Growth Factor Inhibitor Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Vascular Endothelial Growth Factor Inhibitor Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Vascular Endothelial Growth Factor Inhibitor Sales Share by Manufacturers (2015-2020)
Table 13. Global Vascular Endothelial Growth Factor Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Vascular Endothelial Growth Factor Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor Inhibitor as of 2019)
Table 15. Vascular Endothelial Growth Factor Inhibitor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Vascular Endothelial Growth Factor Inhibitor Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Vascular Endothelial Growth Factor Inhibitor Price (2015-2020) (USD/Unit)
Table 18. Vascular Endothelial Growth Factor Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Vascular Endothelial Growth Factor Inhibitor Product Type
Table 20. Date of International Manufacturers Enter into Vascular Endothelial Growth Factor Inhibitor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 23. Global Vascular Endothelial Growth Factor Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Vascular Endothelial Growth Factor Inhibitor Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Vascular Endothelial Growth Factor Inhibitor Revenue Share by Type (2015-2020)
Table 26. Vascular Endothelial Growth Factor Inhibitor Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 28. Global Vascular Endothelial Growth Factor Inhibitor Sales Share by Application (2015-2020)
Table 29. North America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2015-2020) (K Units)
Table 30. North America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2015-2020)
Table 31. North America Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2015-2020)
Table 33. North America Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 34. North America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Table 35. North America Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 36. North America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Table 37. Europe Vascular Endothelial Growth Factor Inhibitor Sales by Country (2015-2020) (K Units)
Table 38. Europe Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2015-2020)
Table 39. Europe Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2015-2020)
Table 41. Europe Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 42. Europe Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Table 43. Europe Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 44. Europe Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Table 53. Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Country (2015-2020) (K Units)
Table 54. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2015-2020)
Table 57. Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 58. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Table 59. Latin America Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 60. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. AstraZeneca Corporation Information
Table 80. AstraZeneca Description and Major Businesses
Table 81. AstraZeneca Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. AstraZeneca Product
Table 83. AstraZeneca Recent Development
Table 84. Bayer Healthcare Corporation Information
Table 85. Bayer Healthcare Description and Major Businesses
Table 86. Bayer Healthcare Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bayer Healthcare Product
Table 88. Bayer Healthcare Recent Development
Table 89. Merck Corporation Information
Table 90. Merck Description and Major Businesses
Table 91. Merck Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Merck Product
Table 93. Merck Recent Development
Table 94. Genetech Corporation Information
Table 95. Genetech Description and Major Businesses
Table 96. Genetech Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Genetech Product
Table 98. Genetech Recent Development
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Description and Major Businesses
Table 101. Eli Lilly Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Eli Lilly Product
Table 103. Eli Lilly Recent Development
Table 104. Sanofi Aventis Corporation Information
Table 105. Sanofi Aventis Description and Major Businesses
Table 106. Sanofi Aventis Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sanofi Aventis Product
Table 108. Sanofi Aventis Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Bristol-Myer Squibb Corporation Information
Table 115. Bristol-Myer Squibb Description and Major Businesses
Table 116. Bristol-Myer Squibb Vascular Endothelial Growth Factor Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Bristol-Myer Squibb Product
Table 118. Bristol-Myer Squibb Recent Development
Table 119. Boehringer Ingelheim Corporation Information
Table 120. Boehringer Ingelheim Description and Major Businesses
Table 121. Boehringer Ingelheim Vascular Endothelial Growth Factor Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Boehringer Ingelheim Product
Table 123. Boehringer Ingelheim Recent Development
Table 124. Global Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Vascular Endothelial Growth Factor Inhibitor Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Vascular Endothelial Growth Factor Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Vascular Endothelial Growth Factor Inhibitor Players
Table 142. Vascular Endothelial Growth Factor Inhibitor Customers List
Table 143. Vascular Endothelial Growth Factor Inhibitor Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Vascular Endothelial Growth Factor Inhibitor Product Picture
Figure 2. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Medications Product Picture
Figure 4. Injections Product Picture
Figure 5. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centers
Figure 8. Cancer Research Institutes
Figure 9. Vascular Endothelial Growth Factor Inhibitor Report Years Considered
Figure 10. Global Vascular Endothelial Growth Factor Inhibitor Market Size 2015-2026 (US$ Million)
Figure 11. Global Vascular Endothelial Growth Factor Inhibitor Sales 2015-2026 (K Units)
Figure 12. Global Vascular Endothelial Growth Factor Inhibitor Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region (2015-2020)
Figure 14. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region in 2019
Figure 15. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region (2015-2020)
Figure 16. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region in 2019
Figure 17. Global Vascular Endothelial Growth Factor Inhibitor Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor Inhibitor Revenue in 2019
Figure 19. Vascular Endothelial Growth Factor Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type (2015-2020)
Figure 21. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Type in 2019
Figure 22. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Type (2015-2020)
Figure 23. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Type in 2019
Figure 24. Global Vascular Endothelial Growth Factor Inhibitor Market Share by Price Range (2015-2020)
Figure 25. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application (2015-2020)
Figure 26. Global Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Application in 2019
Figure 27. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Application (2015-2020)
Figure 28. Global Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Application in 2019
Figure 29. North America Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country in 2019
Figure 32. North America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country in 2019
Figure 33. U.S. Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Vascular Endothelial Growth Factor Inhibitor Market Share by Type in 2019
Figure 38. North America Vascular Endothelial Growth Factor Inhibitor Market Share by Application in 2019
Figure 39. Europe Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country in 2019
Figure 42. Europe Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country in 2019
Figure 43. Germany Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Vascular Endothelial Growth Factor Inhibitor Market Share by Type in 2019
Figure 54. Europe Vascular Endothelial Growth Factor Inhibitor Market Share by Application in 2019
Figure 55. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Region in 2019
Figure 58. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Region in 2019
Figure 59. China Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Market Share by Type in 2019
Figure 82. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Market Share by Application in 2019
Figure 83. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country in 2019
Figure 86. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country in 2019
Figure 87. Mexico Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Vascular Endothelial Growth Factor Inhibitor Market Share by Type in 2019
Figure 94. Latin America Vascular Endothelial Growth Factor Inhibitor Market Share by Application in 2019
Figure 95. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue Market Share by Country in 2019
Figure 99. Turkey Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Market Share by Type in 2019
Figure 106. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Market Share by Application in 2019
Figure 107. North America Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Vascular Endothelial Growth Factor Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

以下、関連資料のご紹介

血管内皮増殖因子Bの世界市場（～2026年）

Global Vascular Endothelial Growth Factor B Market Insights and Forecast to 2026
MRC2-11QY12961 2020年11月30日 117Pages
当調査資料は血管内皮増殖因子Bのグローバル市場について調査・分析したレポートです。種類別（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）市場規模、用途別（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年）

Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market Insights and Forecast to 2026
MRC2-11QY01690 2020年11月20日 117Pages
当調査資料は核因子カッパBキナーゼサブユニットベータ阻害剤のグローバル市場について調査・分析したレポートです。種類別（TLX-1423、IMD-0560、EC-70124、その他）市場規模、用途別（結腸直腸がん、乳がん、膵臓がん、前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

低酸素誘導因子1アルファ阻害剤の世界市場（～2026年）

Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Insights and Forecast to 2026
MRC2-11QY01524 2020年11月20日 119Pages
当調査資料は低酸素誘導因子1アルファ阻害剤のグローバル市場について調査・分析したレポートです。種類別（BC-001、CASI-2ME2、CRLX-101、その他）市場規模、用途別（固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

血漿プロテアーゼC1阻害剤治療の世界市場（～2026年）

Global Plasma Protease C1-inhibitor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04283 2020年11月20日 95Pages
当調査資料は血漿プロテアーゼC1阻害剤治療のグローバル市場について調査・分析したレポートです。種類別（C1阻害剤、カリクレイン阻害剤（カルビトール））市場規模、用途別（病院薬局、独立型薬局・アウトレット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

血管プロテーゼの世界市場（～2026年）

Global Vascular Prostheses Market Size, Status and Forecast 2020-2026
MRC2-11QY04980 2020年11月20日 125Pages
当調査資料は血管プロテーゼのグローバル市場について調査・分析したレポートです。種類別（合成プロテーゼ（ePTFEまたはポリエステル）、生物学的プロテーゼ、生合成プロテーゼ）市場規模、用途別（動脈、静脈）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

間質血管画分の世界市場（～2026年）

Global Stromal Vascular Fraction Market Size, Status and Forecast 2020-2026
MRC2-11QY04746 2020年11月20日 92Pages
当調査資料は間質血管画分のグローバル市場について調査・分析したレポートです。種類別（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品）市場規模、用途別（病院、専門クリニック、幹細胞バンク/研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨー...

第IX因子欠乏症治療の世界市場（～2026年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11918 2020年11月25日 96Pages
当調査資料は第IX因子欠乏症治療のグローバル市場について調査・分析したレポートです。種類別（血友病B、血友病B阻害剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

インテグリンベータ3の世界市場（～2026年）

Global Integrin Beta 3 Market Insights and Forecast to 2026
MRC2-11QY01761 2020年11月20日 110Pages
当調査資料はインテグリンベータ3のグローバル市場について調査・分析したレポートです。種類別（MSP-68、OCU-200、AC-301、C-16Y、その他）市場規模、用途別（黒色腫、動脈血栓症、糖尿病性黄斑浮腫、肺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年）

Global Plasminogen Activator Inhibitor 1 Market Insights and Forecast to 2026
MRC2-11QY13826 2020年11月30日 112Pages
当調査資料はプラスミノーゲンアクチベーター阻害剤1のグローバル市場について調査・分析したレポートです。種類別（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他）市場規模、用途別（血栓症、急性虚血性脳卒中、動脈血栓症、高血圧症、その他）市場規模、地域別（北米、米国、カナダ、ヨ...

IDO阻害剤の世界市場（～2026年）

Global IDO inhibitor Market Insights and Forecast to 2026
MRC2-11QY01540 2020年11月20日 110Pages
当調査資料はIDO阻害剤のグローバル市場について調査・分析したレポートです。種類別（小分子、細胞療法、非公開）市場規模、用途別（がん、アルツハイマー病、うつ病、白内障）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

血管内皮増殖因子Bの世界市場（～2026年） Market Analysis and Insights: Global Vascular Endothelial Growth Factor B Market The global Vascular Endothelial Growth Factor B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vascular Endothelial Growth Factor B Scop…
核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…
低酸素誘導因子1アルファ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market The global Hypoxia Inducible Factor 1 Alpha Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypoxia Inducible Factor 1 Al…
血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
間質血管画分の世界市場（～2026年） Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body. With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, …